Percutaneous Implantation of Subcutaneous Prosthetic Ureters: Long-Term Outcome

Jabbour, Michel E.; Desgrandchamps, François; Angelescu, E; Teillac, P.; Duc, A. Le

doi:10.1089/089277901750426391

Cited by 45 publications

(27 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Up to now, no occlusion or encrustation with urine retention has been observed in this system [6,19,20] . In patients with nephrocutaneous bypass, handling of stomal appliances was facilitated, and rehospitalization for nephrostomy exchange was avoided [19] . The nephrocutaneous bypass as an open system carries a higher risk of complications.…”

Section: Discussionmentioning

confidence: 67%

Subcutaneous Nephrovesical and Nephrocutaneous Bypass

Jurczok

Loertzer²,

Wagner³

et al. 2005

Gynecol Obstet Invest

View full text Add to dashboard Cite

Objective: We evaluated the effectiveness of the subcutaneous bypass for ureteral obstruction in patients with advanced malignancies. Two versions of the minimally invasive technique were performed: nephrovesical and nephrocutaneous bypass. Methods: A specially designed composite implant consisting of an inner smooth silicone-covered tube covered by a coiled e-PTFE-tube was used in 14 patients. Results: 10 subcutaneous nephrovesical bypasses were inserted in 10 patients, 8 nephrocutaneous bypasses in 4 patients. During the mean follow-up period of 13.1 months complications were observed in 2 patients with nephrocutaneous bypass, one encrustation and one infection of the bypass system. Conclusions: The subcutaneous nephrovesical and nephrocutaneous bypass is a safe alternative for palliative treatment of ureteral obstruction caused by pelvic malignancy.

show abstract

Section: Discussionmentioning

confidence: 67%

Subcutaneous Nephrovesical and Nephrocutaneous Bypass

Jurczok

Loertzer²,

Wagner³

et al. 2005

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…Interestingly, other studies involving renal transplant recipients with follow-up of to 15 years had no cases of encrustation or obstruction. [15][16][17] Perhaps the encrustations/stones seen in Case 2 may have been related to chronic fungal infections. Despite these infections, renal function remained stable in this patient.…”

Section: Discussionmentioning

confidence: 99%

Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis

Haddad

Andonian

Anidjar

2013

CUAJ

View full text Add to dashboard Cite

Ureteral obstruction causing renal failure is the most common complication associated with retroperitoneal fibrosis (RPF). Initial management includes steroid therapy together with ureteral stenting. When these fail, ureterolysis is the recommended surgical procedure. However, this could be challenging and recurrence is common. The aim of the present case series was to assess the feasibility of inserting simultaneous bilateral subcutaneous pyelovesical bypass grafts (SPBGs) in patients presenting with RPF who had failed initial endourologic/surgical management.

show abstract

“…In 3 cases, the EAS had to be removed due skin erosion in one and local tumour progression with bladder fistulae in two patients. Otherwise, five patients survived with the prosthesis in situ and a follow-up as long as 84 months without encrustation, infection, obstruction, or skin problems and with normally functioning kidneys (Jabbour et al, 2001). A prospective evaluation of their patients' quality using the EORTC QLC-30 questionnaire following insertion of the Detour EAS demonstrated an improvement of the function scale as a result of the elimination of the external percutaneous tube and a parallel worsening of the symptom scale secondary to the progression of disease (http://groups.eortc.be/qol/ questionnaires_qlqc30.htm).…”

Section: Discussion Of Resultsmentioning

confidence: 99%